Mr. John Bathery - 14 Oct 2025 Form 3 Insider Report for InMed Pharmaceuticals Inc. (INM)

Role: Director
Signature: /s/ Eric Adams, attorney-in-fact for Mr. John Bathery
Issuer symbol: INM
Transactions as of: 14 Oct 2025
Net transactions value: $0
Form type: 3
Filing time: 23 Oct 2025, 19:31:21 UTC
Next filing: 19 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Bathery John Steven	Director	C/O INMED PHARMACEUTICALS INC, 1445-885 WEST GEORGIA ST., VANCOUVER, BRITISH COLUMBIA, CANADA	/s/ Eric Adams, attorney-in-fact for Mr. John Bathery	23 Oct 2025	0002093653

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	INM	Employee Stock Option (Right to Buy)							14 Oct 2025	Common shares	3,500	$2.10	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options were granted on Oct 17, 2025 and will vest monthly, in arrears, as follows: (i) 98 stock options will vest on the 17th day of each month for 35 months, and (ii) 70 stock options will vest on Oct 17, 2025 (the three year anniversary of Grant date).

Remarks:

Exhibit 24 - Power of Attorney